HLA-class II antigen induction does not exclude a diagnosis of cyclosporine nephrotoxicity.
Fuggle
S V
SV
Nuffield Dept of Surgery, University of Oxford, John Radcliffe Hospital, England.
McWhinnie
D L
DL
Morris
P J
PJ
D001379:Azathioprine / Q000627:therapeutic use; D001706:Biopsy; D003524:Cyclosporins / Q000009:adverse effects* / Q000627:therapeutic use; D006084:Graft Rejection; D000949:Histocompatibility Antigens Class II / Q000096:biosynthesis*; D006801:Humans; D007668:Kidney / Q000276:immunology / Q000473:pathology; D016030:Kidney Transplantation; D011239:Prednisolone / Q000627:therapeutic use
D003524:Cyclosporins; D000949:Histocompatibility Antigens Class II; D011239:Prednisolone; D001379:Azathioprine